PetVivo HoldingsPETV -4.65%31 PS Ratio is 21.05 as of Jul. 06, 2026, which is 96% below its 10-year median of 595.41. GuruFocus rates PETV with a GF Score™ of 31/100 and a GF Value™ of $0.51 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 805 Medical Devices & Instruments companies, PetVivo Holdings ranks worse than 91.06% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, PetVivo Holdings's share price is $0.80.
PetVivo Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.04. Hence, PetVivo Holdings's PS Ratio for today is 21.05.
The historical rank and industry rank for PetVivo Holdings's PS Ratio or its related term are showing as below:
PETV'
s PS Ratio Range Over the Past 10 Years
Min: 6.61 Med: 595.41 Max: 9111.11
Current: 21.05
During the past 13 years, PetVivo Holdings's highest PS Ratio was 9111.11. The lowest was 6.61. And the median was 595.41.
PETV's PS Ratio is ranked worse than 91.06% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs PETV: 21.05
PetVivo Holdings Inc revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of PetVivo Holdings was -30.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -25.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 71.00% per year.
During the past 13 years, PetVivo Holdings's highest 3-Year average Revenue per Share Growth Rate was 348.10% per year. The lowest was -30.70% per year. And the median was 43.85% per year.
Back to Basics: PS Ratio
PetVivo Holdings (OTCPK:PETV) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
PetVivo Holdings PS Ratio Related Terms
PetVivo Holdings PS Ratio Historical Data
* Premium members only.
The historical data trend for PetVivo Holdings's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, PetVivo Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetVivo Holdings PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where PetVivo Holdings's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
PetVivo Holdings's Share Price of today is $0.80. PetVivo Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PetVivo Holdings (PETV) has a PS Ratio of 21.05 as of Jul. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PetVivo Holdings and its competitors. This is 96% below median its historical median of 595.41. Over the past decade, PetVivo Holdings' PS Ratio has ranged from 6.61 to 9,111.11. According to the industry distribution chart, PetVivo Holdings ranks #733 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 91.1%.
Is PetVivo Holdings' PS Ratio too high?
PetVivo Holdings' current PS Ratio of 21.05 is 96% below median its 10-year median of 595.41. Over the past 10 years, this metric has ranged from a low of 6.61 to a high of 9,111.11. The Medical Devices & Instruments industry median PS Ratio is 2.94. PetVivo Holdings' value of 21.05 is 616% above this industry median. Based on the distribution chart, PetVivo Holdings ranks #733 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PetVivo Holdings has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PetVivo Holdings' PS Ratio compare to ARAY and RDGL?
According to the Medical Devices & Instruments industry distribution chart, PetVivo Holdings ranks #733 out of 805 companies for PS Ratio. This places PetVivo Holdings in the lower half of its industry. The industry median PS Ratio is 2.94. PetVivo Holdings' value of 21.05 is 616% above this benchmark. Historically, PetVivo Holdings' own PS Ratio has ranged from 6.61 to 9,111.11 over the past decade. While the company's 10-year median is 595.41 vs. the industry median of 2.94, PetVivo Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PetVivo Holdings's current PS Ratio of 21.05 is 616% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PetVivo Holdings and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PetVivo Holdings's current PS Ratio is 21.05, which is 96% below median its own 10-year median of 595.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetVivo Holdings stock overvalued right now?
Based on GuruFocus' analysis, PetVivo Holdings (PETV) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.51, compared to a current price of $0.80 — trading 56.9% above its estimated fair value. The current PS Ratio is 21.05, which is 96% below median its 10-year median of 595.41 and 616% above the Medical Devices & Instruments industry median of 2.94. PetVivo Holdings' overall GF Score™ is 31/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For PetVivo Holdings (PETV), the current PS Ratio is 21.05 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PetVivo Holdings (PETV) Overvalued in 2026?
Based on GuruFocus' analysis, PetVivo Holdings stock appears to be overvalued.
The current stock price of $0.80 is trading 56.9% above its estimated GF Value™ of $0.51.
GuruFocus considers PetVivo Holdings to be Significantly Overvalued.
Key valuation signals for PETV:
PS Ratio: 21.05 (96% below median its 10-year median of 595.41)
GF Value™: $0.51 vs. price of $0.80 (56.9% above fair value)
Industry Position: 616% above the Medical Devices & Instruments median (#733 of 805)
No single metric tells the full story. See the PETV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.
31GF Score
Get the complete analysis for PETV
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETV has been successfully added to your 
